Canada: Error In Registering Trade-Mark Must Be Corrected Via Section 57 Of The "Trade-Marks Act" (Intellectual Property Weekly Abstracts Bulletin: Week Of December 16, 2013)

Last Updated: December 19 2013
Most Read Contributor in Canada, September 2016

Edited by Chantal Saunders and Beverley Moore and Adrian Howard


Error in Registering Trade-mark Must be Corrected via Section 57 of the Trade-marks Act

299614 Alberta Ltd. v. Fresh Hemp Foods Ltd., 2013 FC 1245

The Registrar of Trade-marks (Registrar) allowed the trade-mark application by Fresh Hemp Foods. 299614 Alberta (the Applicant) appealed the decision pursuant to section 56(1) of the Trade-marks Act.

The Court held that it was clear that the registration was allowed because the Registrar erroneously thought the opposition to the registration had been withdrawn. Although the Court found that Fresh Hemp Foods was granted rights that it would not otherwise have had because of this error, the Court held that the correct way to proceed is to commence expungement proceedings pursuant to section 57, and not an appeal pursuant to section 56. Accordingly, the application was dismissed.

Palpable and Overriding Error Found by Court of Appeal in Considering New Evidence to be Material

Kelly Properties v. Canadian Council of Professional Engineers, 2013 FCA 287

The Court found that additional evidence provided by the Respondents would have materially affected the outcome at the Trade-marks Opposition Board (Board). The Court of Appeal held that the Court committed a palpable and overriding error in making this finding. In particular, the Court of Appeal found that the evidence of two witnesses about the interpretation of the Engineering and Geoscience Professions Act was irrelevant, the additional affidavits added no new material facts compared to what was before the Board, and the Board's decision was not unreasonable. The appeal was allowed.


Court of Appeal Confirms that Subsequent Declaration of Invalidity does not Vary Order of Prohibition

Apotex Inc. v. Eli Lilly Canada Inc., 2013 FCA 282

The issue to be determined by the Court of Appeal in this appeal was whether an Order of prohibition in a proceeding pursuant to the Patented Medicines (Notice of Compliance) Regulations can be varied pursuant to Rule 399 of the Federal Courts Rules, as a result of a declaration of invalidity in a subsequent proceeding. The Court dismissed the motion, and Apotex appealed the finding.

The Court of Appeal noted that, in an unrelated proceeding, the Court of Appeal previously has held that an order of prohibition does not get set aside when a patent is declared invalid, and that Apotex must convince the Court of Appeal that this decision is manifestly wrong in order to succeed.

The Court of Appeal held that they were not persuaded that the Court committed a reviewable error but noted that arguments to the effect that prior decisions are bad law are better addressed through an application for leave to appeal to the Supreme Court of Canada.

Fact-specific Issues Relevant to Calculating Section 8 Damages are Decided

Apotex Inc. v. Takeda Canada Inc., 2013 FC 1237

This decision provides answers to certain issues that would allow the parties to calculate the loss under section 8 of the PM(NOC) Regulations that arose from an earlier decision of the Federal Court. In that earlier decision, Apotex's allegations of non-infringement for the product pantoprazole were found to be justified.

The issues left to be resolved in this proceeding included: 1) the burden of proof; 2) the number and identity of generic market entrants; 3) market share; 4) price; 5) inventory adjustment; 6) double ramp-up; 7) rebates; 8) interest; and 9) discretion to reduce the award based on Apotex's misconduct.

This was a highly fact-based exercise, but the Court did decide to not deduct the "ramp up" period at the start of the relevant period because a "ramp up" was experienced by Apotex in the real world. In distinguishing precedent, the Court considered that adding it in a second time was seen as doubling the ramp up to the detriment of the generic company.

Prejudgment interest was calculated from the quarter proceeding the date the Apotex sent their statement of claim, calculated from the patent hold date.

Takeda had argued that the award should be reduced by Apotex's alleged breach of undertaking. In the NOA, Apotex had stated that "[e]ach of the claims of the '748 Patent includes as an essential element a Helicobacter-inhibiting anti-microbial agent. Our sodium pantoprazole tablets shall not contain said agent, as that term is construed in accordance with the claims of the '748 Patent, nor shall our tablets be marketed or promoted to doctors, pharmacists or others to be used in combination with a Helicobacter-inhibiting anti-microbial agent or as part of a medicament package comprising said agent. As such, our tablets shall not infringe any of the claims of the '748 patent."

The Court declined to find that the allegation within Apotex's NOA rose to the level of an undertaking to be relied upon by the Court. Therefore, the fact that Apotex took no steps to prevent the marketing and promoting of their product for the treatment of Helicobacter pylori was of no consequence.


Health Canada has published a number of new and updated forms: Notice – Post- Notice of Compliance (NOC) Changes: Notices of Change (Level III) Form; Drug Master File (DMF) Application Form; Health Canada 3011: Drug Submission Application Form for Human, Veterinary, Disinfectant Drugs and Clinical Trial Application/Attestation; and Clinical Trials Site Information Form.

Health Canada has started a Consultation – Data requirements for switching medicinal ingredients from prescription to non-prescription status.

The PMPRB has released two new analytical reports under the National Prescription Drug Utilization Information System (NPDUIS) Initiative: The Drivers of Prescription Drug Expenditures – A Methodological Report and The New Drug Pipeline Monitor (5th Ed).

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.